Home > Insider Trading > Filing (0001562180-19-003095)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597553	Sage Therapeutics Inc.	SAGE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1704336	Michael Cloonan	C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142	Chief Business Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-22	25,000	$73.43	25,461	No	4	M	Direct
Common Stock	Disposition	2019-05-22	25,000	$175.00	461	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-05-22	25,000	$0.00	25,000	$73.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
160,000		2027-05-01	No	4	M	Direct

Footnotes

The 461 shares reported as beneficially owned were acquired by the reporting person pursuant to the issuer's employee stock purchase plan.
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The securities awarded on 5/01/2017 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2016 Inducement Equity Plan. Options to purchase 46,250 shares of common stock vested on April 24, 2018 with 138,750 shares vesting in 36 equal monthly installments thereafter.